- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01628302
Effect of Salt Restriction on Renin Activation
Investigation of Salt Restriction Effect on Renin Activation
The present prospective, randomized, crossover study is designed to investigate the effect of salt consumption on blood pressure in hypertensive subjects.
Secondary objectives of the study are to evaluate the effect of salt consumption on blood pressure among the subjects who are hypertensive and obese and normal according to body mass index and to evaluate the effect of salt consumption on renin activity in hypertensive subjects.
Studieoversikt
Detaljert beskrivelse
The present study is carried out with the subjects who are chosen among the nursing home residents in İzmir. The subjects were randomized to 2 groups and while one of these groups had low salt diet (50mmol), the other group had normal salt diet (250mmol) for 3 weeks. Subjects had normal salt diet in their daily routine life for the following 2 weeks. According to crossover nature of the study, the group that had normal salt diet at the first 3 weeks of study had low salt diet at the last 3 weeks of the study. The other group that had low salt diet had the normal salt diet at the last 3 week of the study.
At the beginning of the study, information such as demographic, family story, medical story, diet habits, concomitant medication and physical measurements (height, weight and waist circumference) were received from the subjects.
24 hour blood pressure of the subjects is measured for four times, before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet. The subjects were asked for collecting 24-h urine in the same days of blood pressure measurement. Sodium, potassium, urea, creatinin and microalbumin measurements were measured in the collected urine. Blood samples were collected for three times, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet. Plasma renin activity and aldosterone levels were measured in the blood samples collected. Aldosterone level was measured in the 24-hour urine in mentioned days.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Subjects who are 50 years and older
- Subjects whose systolic blood pressure is ≥ 140 mmHg
- Subjects whose diastolic blood pressure is ≥ 90 mmHg
- Subjects who is normal weighted defined as body mass index < 25 or who is obese defined as body mass index > 30
- Subjects who have intellectual capacity to adapt diets and 24 hour urine collection
- Informed about the study and consented to include the study
Exclusion Criteria:
- Known heart failure
- Known renal failure
- Known chronic liver disease
- Antihypertensive drug use
- nonsteroidal anti inflammatory (NSAI) drug use
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Ingen inngripen: Normal salt diet
The group had normal salt diet (250mmol)for three weeks.
Subjects had normal salt diet in their daily routine life for the following 2 weeks.According to crossover nature of the study, the group had low salt diet (50mmol) at the last 3 weeks of the study.
|
|
Eksperimentell: Low salt diet
The group had low salt diet (50mmol)for three weeks.
Subjects had normal salt diet in their daily routine life for the following 2 weeks.According to crossover nature of the study, the group had normal salt diet at the last 3 weeks of the study.
|
Low salt diet (50mmol)for three weeks.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change from baseline in 24-hour ambulatory blood pressure at 3 weeks
Tidsramme: 3 weeks
|
24-hour ambulatory blood pressure was measured before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Change in sodium levels in urine samples.
Tidsramme: 3 weeks
|
Sodium was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Change in plasma renin activity
Tidsramme: For 3 times in 8 weeks
|
Plasma renin activity level was measured in the blood samples collected, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
For 3 times in 8 weeks
|
Change in aldosterone level in blood samples
Tidsramme: For 3 times in 8 weeks
|
Aldosterone levels was measured in the blood samples collected , at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
For 3 times in 8 weeks
|
Change in potassium levels in urine samples.
Tidsramme: 3 weeks
|
Potassium was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Change in urea level in urine samples
Tidsramme: 3 weeks
|
Urea was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet
|
3 weeks
|
Change in creatinin level in urine samples
Tidsramme: 3 weeks
|
Creatinin was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
3 weeks
|
Change in microalbumin level in urine samples
Tidsramme: 3 weeks
|
Microalbumin was measured in 24-hour collected urine samples before the beginning of diet specific to their groups, at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet
|
3 weeks
|
Change in aldosterone level in urine samples
Tidsramme: For 3 times in 8 weeks
|
Aldosterone levels was measured in in the 24-hour urine samples collected , at the end of the 3-week diet, before the beginning of the second diet and at the end of their second diet.
|
For 3 times in 8 weeks
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Mustafa Arici, Prof., Hacettepe University Faculty of Medicine Department of Nephrology
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- HT-Salt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Hypertensjon
-
University Hospital of CologneUkjentNAFLD; Hypertensjon, White-Coat Hypertension, Masked HypertensionTyskland
-
Karolinska InstitutetFullførtWhite Coat Hypertension
-
Clinical Hospital Centre ZagrebEuropean Society of HypertensionUkjentWhite Coat Hypertension | Blodtrykk | LivsstilsrisikoreduksjonIsrael, Hellas, Belgia, Tyskland, Armenia, Østerrike, Bulgaria, Kroatia, Tsjekkia, Estland, Italia, Libanon, Litauen, Nederland, Polen, Portugal, Romania, Serbia, Spania, Sverige, Ukraina, Storbritannia
-
Regional Hospital HolstebroFullførtSunn | White Coat Hypertension | Essensiell hypertensjonDanmark
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Aktiv, ikke rekrutterendeWhite Coat Hypertension | Hypertensjon, viktigForente stater
-
University of Alabama at BirminghamTroy UniversityFullførtHypertensjon | Hypertensjon, motstandsdyktig mot konvensjonell terapi | Ukontrollert hypertensjon | Hypertensjon, hvit pelsForente stater
-
PD Dr. Grégoire WuerznerSwiss National Science FoundationFullførtHypertensjon | Overvekt | White Coat Hypertension | Resistent hypertensjonSveits
-
University Hospital, ToursFullførtPTFE-dekkede stenter versus nakne stenter i TIPS (Transjugulær Intra-hepatisk Porto-systemisk shunt)Cirrhotic Portal HypertensionFrankrike
-
Sun Yat-sen UniversityFullførtHepatocellulært karsinom (HCC) | Cirrhotic Portal HypertensionKina
Kliniske studier på Lowering salt in diet
-
Seoul National University HospitalUkjentKompleks regionalt smertesyndromKorea, Republikken
-
Mayo ClinicNational Cancer Institute (NCI)FullførtTilbakevendende voksent diffust storcellet lymfom | Tilbakevendende grad 1 follikulært lymfom | Tilbakevendende grad 2 follikulært lymfom | Tilbakevendende grad 3 follikulært lymfom | Tilbakevendende mantelcellelymfom | Tilbakevendende marginalsone lymfom | Marginal sone lymfom i milten | Waldenstrom... og andre forholdForente stater
-
Children's Oncology GroupNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeEkstraokulært retinoblastomForente stater, Canada, Australia, Brasil, Argentina, Egypt
-
Children's Oncology GroupNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeLokalisert resektabelt nevroblastom | Lokalisert uoperabelt nevroblastom | Regionalt nevroblastom | Stage 4S Neuroblastom | Ganglioneuroblastom | Stadium 4 NevroblastomForente stater
-
National Cancer Institute (NCI)FullførtAkutt lymfatisk leukemi | Voksen B Akutt lymfatisk leukemi med t(9;22)(q34.1;q11.2); BCR-ABL1Forente stater
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)FullførtAkutt myeloid leukemi | Akutt lymfatisk leukemiForente stater